Wiktoria Lewicka

Wiktoria Lewicka

Auto-generated profile, based on publicly available information

Wiktoria Lewicka

Lower Silesian Center for Oncology, Pulmonology and Hematology in Wroclaw

Research Focus & Metrics

Academic Career Length

2Years (2025-Present)

(Calculated once Scilit publication data is synced: current year − year of first publication + 1)

Representative Publications

View All Publications
26 April 2025 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
WLWiktoria Lewicka
Wiktoria Lewicka
ISIzabella Sośniak
Izabella Sośniak
KSKonrad Szaliński
Konrad Szaliński
ESEwa Szczęsna
Ewa Szczęsna
Introduction and purpose of the study: Anxiety and depressive disorders are among the most prevalent and debilitating mental health conditions, significantly impacting global health and quality of life. Current pharmacological and psychotherapeutic treatments, while effective, face challenges such as limited accessibility, high costs, and stigma. Resistance training (RT) seems a promising non-pharmacological intervention for the prevention and management of these disorders. This review evaluates the efficacy of resistance training in preventing and treating anxiety and depression, with a focus on its biological and psychological mechanisms and effectiveness across diverse populations. Summary: RT significantly alleviates symptoms of anxiety and depression across diverse populations. Biological mechanisms include improved stress regulation and reduced inflammation. Psychological benefits encompass better self-esteem, improved sleep quality and emotional well-being. Structured and supervised RT programs show the greatest efficacy, with additional benefits observed in specific groups such as older adults and individuals with chronic conditions. Resistance training is an effective intervention to improve mental health outcomes. Future research should explore optimal RT protocols, long-term outcomes, and integration into multimodal treatments.

8 July 2025 in Journal of Education, Health and Sport
Verified
Journal Article
Open access
PDF file
AJArkadiusz Jaworski
Arkadiusz Jaworski
MSMichał Szyszka
Michał Szyszka
KBKarolina Brzostek
Karolina Brzostek
JSJakub Sobieraj Sobieraj
Jakub Sobieraj Sobieraj
WLWiktoria Lewicka
Wiktoria Lewicka
ISIzabella Sośniak
Izabella Sośniak
Introduction and purpose:Sleep deprivation (SD), paradoxically, has been shown to induce rapid antidepressant effects in patients with depressive disorders. This review explores the neurobiological underpinnings, clinical efficacy, and therapeutic strategies involving SD, aiming to clarify the mechanisms responsible for its mood-elevating effects and to assess its role in modern treatment of depression. Description of the state of knowledge:Clinical evidence consistently shows that a single night of total or partial SD can lead to a rapid reduction in depressive symptoms in approximately 40–60% of patients. However, these effects are short-lived, with relapse typically occurring after recovery sleep. Combination therapies, such as SD with phase advance and bright light exposure, have been developed to prolong therapeutic benefits. On the neurobiological level, SD appears to act through multiple pathways: resetting dysregulated circadian rhythms, enhancing monoaminergic neurotransmission (particularly serotonin and dopamine), upregulating brain-derived neurotrophic factor (BDNF), and inducing synaptic plasticity. Acute activation of the hypothalamic–pituitary–adrenal axis and transient increases in inflammatory markers have also been observed, suggesting a complex physiological adaptation that accompanies mood improvement. Additionally, glial mechanisms involving adenosine signaling may contribute to the antidepressant response. Summary:Sleep deprivation represents a unique, non-pharmacological intervention capable of rapidly alleviating depressive symptoms. Although transient on its own, its combination with chronotherapeutic or pharmacological strategies offers promising avenues for sustained therapeutic effect. Insights from SD research deepen our understanding of depression’s neurobiology and support the development of fast-acting antidepressant treatments that target circadian and neuroplastic mechanisms.

9 August 2025 in Quality in Sport
Verified
Journal Article
Open access
PDF file
ASAlina Semianiuk
Alina Semianiuk
MSMałgorzata Stopa
Małgorzata Stopa
ESEwa Szczęsna
Ewa Szczęsna
PDPaweł Drymluch
Paweł Drymluch
WLWiktoria Lewicka
Wiktoria Lewicka
AMAdrianna Moreń
Adrianna Moreń
Introduction and purposeVitamin B12 deficiency remains an underdiagnosed condition with significant hematological, neurological, and psychiatric consequences. The aim of this review is to evaluate and compare the efficacy, indications, and clinical applicability of oral, sublingual, intramuscular, and subcutaneous vitamin B12 supplementation routes, and to provide evidence-based recommendations tailored to patient-specific conditions. Brief description of the state of knowledgeVitamin B12 is primarily absorbed in the distal ileum via an intrinsic factor-mediated mechanism. Deficiency is commonly caused by malabsorption syndromes, restrictive diets, medication use, and autoimmune disorders such as pernicious anemia. Intramuscular and subcutaneous administration bypass absorption defects and are considered the gold standard, especially in symptomatic patients. Oral and sublingual routes are increasingly used due to ease of use and cost-effectiveness. Sublingual supplementation, in particular, shows comparable biochemical efficacy to intramuscular injection and offers higher patient satisfaction. However, the variability in absorption and the use of surrogate biomarkers limit the consistency of clinical outcomes across studies. SummaryAll forms of vitamin B12 supplementation can be effective when used appropriately. Intramuscular administration remains superior in cases of severe deficiency and neurological involvement. Oral and sublingual supplementation are suitable for long-term maintenance and mild deficiencies, especially in patients with adherence capacity and no profound malabsorptive conditions. Clinical decision-making should be guided by etiology, severity, patient preference, and logistical feasibility.